Join InSiGHT & ICaN Asia for “CAPP3: Recent Updates and Emerging Insights in Lynch Syndrome Prevention”, featuring Finlay Macrae and a case discussion with genetic counsellor Sook Yee Yoon. 📅 15 October 🕚 17:00 Singapore Time 👉Register now: shorturl.at/aFvwD #LynchSyndrome #CAPP3 #CancerGenetics
International Society for Gastrointestinal Hereditary Tumours
@insight-org.bsky.social
InSiGHT is a multidisciplinary scientific organisation, whose mission is to improve the care of patients and families worldwide with any hereditary condition resulting in gastrointestinal tumours.
🧬 Lynch syndrome–associated colorectal cancers do not rely on a single Wnt pathway mutation. New research reveals a diverse spectrum of genetic alterations driving Wnt activation in MLH1-associated tumors: Read full paper: pubmed.ncbi.nlm.nih.gov/41556860/ #LynchSyndrome #ColorectalCancer
MLH1 Lynch Syndrome Colorectal Cancers Are Driven by Heterogeneous Wnt Pathway Gene Mutations - PubMed
MLH1 Lynch Syndrome Colorectal Cancers Are Driven by Heterogeneous Wnt Pathway Gene Mutations
pubmed.ncbi.nlm.nih.gov
The first-ever InSiGHT #Podcast is here! Dr Sonia Kupfer & Dr Ben Zare speak with Dr Maartje Nielsen and Dr Diantha Terlouw about APC mosaicism in patients with colorectal adenomas, including testing, surveillance and clinical implications. 🎧Watch: youtu.be/NjJXayj975A #HereditaryCancer #GIcancer
Familial adenomatous #polyposis (FAP) extends beyond colorectal disease. This study explores biliary tract neoplasms and their molecular features, offering insights into APC-driven tumour biology and extracolonic cancer risk. Read here: www.jstage.jst.go.jp/article/jarc... #FAP #HereditaryCancer
👩⚕️ Hereditary colorectal cancer care goes beyond genetic testing. Specialist nurses play a key role in risk communication, surveillance adherence, care coordination and family support. 📖 Read more: www.jstage.jst.go.jp/article/jarc... #ColorectalCancer #CancerNursing #Genetics
🚨 1 Day to Go! A single genetic variant can have significant implications for patient care and family risk assessment. But how do we determine whether a variant is pathogenic? Join us for the InSiGHT Webinar: 👉Register here: lnkd.in/ehkvmxcm #Genetics #VariantCuration
🧬 How do experts decide whether a genetic variant is pathogenic? Join the next @InSiGHTgroup webinar featuring Marc Greenblatt, hosted by Benjamin Zare, to explore the science behind variant curation. 📅 Jul 29, 2026 🕛 12 PM EST | 6 PM CET 🔗 Register: shorturl.at/4SnFE #CancerGenetics
❓Pathogenic or not? Join us on July 29 for an #InSiGHT webinar exploring how experts evaluate genetic variants and their clinical significance. Guest speaker: Marc Greenblatt Host: Ben Zare. 💻 Online | 12 PM EST / 6 PM CET Register here: shorturl.at/nbHA4 #CancerGenetics #Genomics #InSiGHT
1/7 🧬 Is the APC I1307K variant more than just a modest CRC risk factor? A new prospective study in @GastroJournal of 21,380 individuals sheds light on long-term cancer risks. A thread for the #HereditaryGI community. Read the full research letter here: www.gastrojournal.org/action/showP...
gastrojournal.org
💚 AYA Awareness Week 🚨Adolescent & Young Adult patients are diagnosed with cancer between 15–39, often during school, careers, relationships, and family planning. Awareness leads to earlier diagnosis & age‑appropriate care. 📖 Read the March 2026 digital magazine: www.nxtbook.com/nxtbooks/nga...
Elephants and Tea - March 2026
Experience our interactive, profoundly engaging digital publication!
nxtbook.com
That’s a wrap on #InSiGHT2026! A huge thank you to our scientific committee, organisers, speakers, participants, sponsors & partners for driving an incredible exchange of ideas. Your commitment to advancing research and care in hereditary GI cancer makes all the difference. 🌟 #InSiGHTcommunity
✨ We were truly privileged to welcome Dr Poh-Koon Koh, Senior Minister of State for Health and Manpower, Singapore, as our Guest of Honour on Day 4 of #InSiGHT2026. It was an inspiring session followed by meaningful discussions. 👏 #GuestOfHonour #AdvancingGIcancerResearch
Another fantastic day at #InSiGHT2026 🔬 Day 3 highlighted major progress in hereditary GI cancers: From gastric & #PancreaticCancer updates to key advances in #LynchSyndrome. Great talks, global insights, and an excellent panel discussion. #GICancerPrevention #MedicalResearch
Colorectal cancer is one of the most preventable ones, yet it remains a leading cause of cancer-related deaths. Let’s raise awareness, encourage screening, support those affected, and continue advancing research that improves prevention, diagnosis, and care. #ColorectalCancer #EarlyDetection
Ready for Day 3 of #InSiGHT2026 ?👀 Don’t miss these exciting sessions: 🧬Session 7: Hereditary Gastric Cancer Surveillance and Management 🔬Session 8: Advances in Pancreatic Cancer Research 🧪Sessions 9 & 10: Advances in Lynch Syndrome Research #InSiGHTCommunity #GIcancer #LynchSyndrome
Day 2 at #InSiGHT2026 delivered! 🚀 Clinical innovation and powerful insights driving #hereditaryGIcancer research forward: from novel genetic drivers to AI in #pathology. Collaboration at its best across Y‑InSiGHT, ClinGen VCEP & Genetic Counsellors Community. @awscloud.bsky.social
Our Young InSiGHT members are off to a strong start of #InSiGHT2026! Day 1 - Padel session full of energy & teamwork Day 2 - Breakfast session with great conversations & new connections And this is only the beginning! We can't wait to see this #InSiGHTCommunity grow 🌟 #GIcancer #YoungInSiGHT
The road to InSiGHT 2026 Singapore officially started! We are thrilled to begin shaping a meeting that will inspire, connect, and advance our field. Kicking off the meeting with a Masterclass in GI Cancer Genomics by Heather Hampel. #InSiGHT2026 #GICancer #BiennialMeeting #PublicHealth #genomics
The countdown is on - #InSiGHT2026 is almost here! From 4–7 March 2026, #HereditaryGICancer experts from around the world will come together in Singapore for the Biennial Meeting at Dusit Thani Laguna Singapore. Still not registered? There’s still time: insight2026.org Singapore awaits you!
Save the Date! Join us for the first Y-InSiGHT webinar on career development for emerging professionals in hereditary GI tumours. 📅 28 January | 🕒 14:00 CET | 💻 Online Register now and find more info 👉 shorturl.at/k773K #YInSiGHT #HereditaryCancer #Genetics #GIOncology #EarlyCareerResearchers
Today’s the final call for late abstract submissions for #InSiGHT2026! 📅 Deadline: Jan 5 Plus, early-bird registration closes Jan 10 – don’t miss your chance to join us in Singapore! Register now insight2026.org #InSiGHT2026 #GIcancer #lateabstractsubmission #GIgenetics
November is Pancreatic Cancer Awareness Month 💜 It’s the deadliest of the common cancers due to late detection. Researchers stress genetic testing - hereditary risk matters. Know your family history. Advocate for early detection. 💜 Read more 👉 shorturl.at/eKuTB #PancreaticCancer #GeneticTesting
Genetic testing and pancreatic cancer: Why is it important?
By Eric Traub | Northside Hospital Cancer Institute Pancreatic cancer: arguably the most haunting pair of words in the medical world. Numerous high-profile people have succumbed to pancreatic cancer a...
shorturl.at
We’re proud to present the current Council members of The International Society for Gastrointestinal Hereditary Tumours (InSiGHT), driving progress in research, collaboration, and patient care worldwide. Learn more about us👉 shorturl.at/6cyJV #Genetics #GIHealth #HereditaryGICancer #InSiGHT
Final Call for Abstracts – Deadline Today!⏳ Don't miss your chance to be part of the #InSiGHT2026 Biennial Meeting in #Singapore! 🌏 🗓️ Submission Deadline: 30 September 2025 ⏰ Time: Midnight (Singapore Time) / 6pm CET Submit your abstract now! insight2026.org/abstract-sub... #Genetics #GIcancer
🚨 Final Call: Abstract submissions for #InSiGHT2026 close TOMORROW – Sept 30! Join the global conversation on hereditary GI tumours. Submit now 👉 insight2026.org Let your research drive progress. #MedicalResearch #Genetics #GIcancer #AbstractSubmission
🚨 It’s here! The Scientific Program for InSiGHT 2026 (4–7 March, Singapore 🇸🇬) is now live! 🔗 Check out the full program: insight2026.org/scientific-programme 🧬 Abstracts due 30 Sept – submit yours: insight2026.org/abstract-submission-guidelines #InSiGHT2026 #HereditaryCancer #GICancerResearch
🌏 InSiGHT Biennial Meeting is coming to Singapore! 📅 4–7 March 2026 📝 Abstract submission extended: now due 30 Sept 2025! Submit your abstract and be part of the conversation shaping the future of the field! www.insight2026.org/abstract-submission-guidelines/ #InSiGHT2026 #GICancerResearch
🚀 Exciting news! We’re launching Young-Insight for InSiGHT members under 40. Join our first meeting to share ideas & shape the future of our community. Email admin@insight-group.org with subject “Young Insight” to get involved! 🌍✨ #InSiGHT
📢 Join us in Singapore for the InSiGHT Biennial Meeting, 4–7 March 2026! 🔹 Abstract Deadline: 20 Sept 2025 🔹 Early Bird: 10 Jan 2026 Link ➡️ insight2026.org Let’s advance hereditary GI cancer research together! #InSiGHT2026 #MedicalResearch #GItumours
👋 Welcome to InSiGHT on BlueSky! We are a global community of researchers, clinicians, and scientists dedicated to advancing the understanding, diagnosis, and management of hereditary GI cancers. Follow us for updates on scientific advances, clinical guidelines, and upcoming events. #InSiGHT